受强制性开放获取政策约束的文章 - Shannon Boye了解详情
可在其他位置公开访问的文章：66 篇
Current clinical applications of in vivo gene therapy with AAVs
JR Mendell, SA Al-Zaidy, LR Rodino-Klapac, K Goodspeed, SJ Gray, ...
Molecular Therapy 29 (2), 464-488, 2021
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research
Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness
MM Doroudchi, KP Greenberg, J Liu, KA Silka, ES Boyden, JA Lockridge, ...
Molecular Therapy 19 (7), 1220-1229, 2011
强制性开放获取政策： US National Institutes of Health
A comprehensive review of retinal gene therapy
SE Boye, SL Boye, AS Lewin, WW Hauswirth
Molecular therapy 21 (3), 509-519, 2013
强制性开放获取政策： US National Institutes of Health
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
CN Kay, RC Ryals, GV Aslanidi, SH Min, Q Ruan, J Sun, FM Dyka, ...
PloS one 8 (4), e62097, 2013
强制性开放获取政策： US National Institutes of Health
Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber’s hereditary optic neuropathy in a mouse model
H Yu, RD Koilkonda, TH Chou, V Porciatti, SS Ozdemir, V Chiodo, ...
Proceedings of the National Academy of Sciences 109 (20), E1238-E1247, 2012
强制性开放获取政策： US National Institutes of Health
Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa
J Pang, X Dai, SE Boye, I Barone, SL Boye, S Mao, D Everhart, ...
Molecular therapy 19 (2), 234-242, 2011
强制性开放获取政策： US National Institutes of Health
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus
VS Lopes, SE Boye, CM Louie, S Boye, F Dyka, V Chiodo, H Fofo, ...
Gene therapy 20 (8), 824-833, 2013
强制性开放获取政策： US National Institutes of Health
The human rhodopsin kinase promoter in an AAV5 vector confers rod-and cone-specific expression in the primate retina
SE Boye, JJ Alexander, SL Boye, CD Witherspoon, KJ Sandefer, ...
Human gene therapy 23 (10), 1101-1115, 2012
强制性开放获取政策： US National Institutes of Health
Dual Adeno-Associated Virus Vectors Result in Efficient In Vitro and In Vivo Expression of an Oversized Gene, MYO7A
FM Dyka, SL Boye, VA Chiodo, WW Hauswirth, SE Boye
Human gene therapy methods 25 (2), 166-177, 2014
强制性开放获取政策： US National Institutes of Health
Functional and behavioral restoration of vision by gene therapy in the guanylate cyclase-1 (GC1) knockout mouse
SE Boye, SL Boye, J Pang, R Ryals, D Everhart, Y Umino, AW Neeley, ...
PloS one 5 (6), e11306, 2010
强制性开放获取政策： US National Institutes of Health
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa
TJ Conlon, WT Deng, K Erger, T Cossette, J Pang, R Ryals, N Clément, ...
Human gene therapy Clinical development 24 (1), 23-28, 2013
强制性开放获取政策： US National Institutes of Health
rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters
WA Beltran, SL Boye, SE Boye, VA Chiodo, AS Lewin, WW Hauswirth, ...
Gene therapy 17 (9), 1162-1174, 2010
强制性开放获取政策： US National Institutes of Health
Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque
KT McCullough, SL Boye, D Fajardo, K Calabro, JJ Peterson, CE Strang, ...
Human gene therapy 30 (5), 571-589, 2019
强制性开放获取政策： US National Institutes of Health
Impact of heparan sulfate binding on transduction of retina by recombinant adeno-associated virus vectors
SL Boye, A Bennett, ML Scalabrino, KT McCullough, K Van Vliet, ...
Journal of virology 90 (8), 4215-4231, 2016
强制性开放获取政策： US National Institutes of Health
Rationally engineered AAV capsids improve transduction and volumetric spread in the CNS
NM Kanaan, RC Sellnow, SL Boye, B Coberly, A Bennett, ...
Molecular Therapy-Nucleic Acids 8, 184-197, 2017
强制性开放获取政策： US National Institutes of Health
Highly efficient delivery of adeno-associated viral vectors to the primate retina
SE Boye, JJ Alexander, CD Witherspoon, SL Boye, JJ Peterson, ME Clark, ...
Human gene therapy 27 (8), 580-597, 2016
强制性开放获取政策： US National Institutes of Health
Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations
WA Beltran, AV Cideciyan, SE Boye, GJ Ye, S Iwabe, VL Dufour, ...
Molecular Therapy 25 (8), 1866-1880, 2017
强制性开放获取政策： US National Institutes of Health
Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness
ML Scalabrino, SL Boye, KMH Fransen, JM Noel, FM Dyka, SH Min, ...
Human molecular genetics 24 (21), 6229-6239, 2015
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs, Genome …
Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency
J Pang, SE Boye, B Lei, SL Boye, D Everhart, R Ryals, Y Umino, B Rohrer, ...
Gene therapy 17 (7), 815-826, 2010
强制性开放获取政策： US National Institutes of Health
Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants
MJ Benskey, NC Kuhn, JJ Galligan, J Garcia, SE Boye, WW Hauswirth, ...
Molecular Therapy 23 (3), 488-500, 2015
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定